Seminars in Oncology
Volume 29, Issue 3 , Pages 222-230 , June 2002

Issues in clinical trial design for tumor marker studies

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address reprint requests to Daniel Sargent, PhD, Director, Cancer Center Statistics, Mayo Clinic Cancer Center, Kahler 1-A, 200 1st St SW, Rochester, MN 55905.

PII: S0093-7754(02)50178-0

doi: 10.1053/sonc.2002.32898

Seminars in Oncology
Volume 29, Issue 3 , Pages 222-230 , June 2002

Article Tools

* Image Usage & Resolution